Bio-Techne Corp Common Stock Earnings Dividend

Bio-Techne Corp Common Stock’s revenue jumped 1.33% since last year same period to $321.19Mn in the Q2 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 3.14% jump in its revenue since last 3-months.

Bio-Techne Corp Common Stock’s net profit jumped 408.92% since last year same period to $54.61Mn in the Q2 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 6.96% jump in its net profits since last 3-months.

Bio-Techne Corp Common Stock’s net profit margin jumped 404.85% since last year same period to 17% in the Q2 2026. On a quarterly growth basis, Bio-Techne Corp Common Stock has generated 3.7% jump in its net profit margins since last 3-months.

Bio-Techne Corp Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.4 - a -13.04% fall from last quarter’s estimates.

Bio-Techne Corp Common Stock’s earning per share (EPS) estimates for the current year stand at 0.4.

Bio-Techne Corp Common Stock’s earning per share (EPS) fell -7.55% since last year same period to 0.49 in the Q2 2026. This indicates that the Bio-Techne Corp Common Stock has generated -7.55% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Bio-Techne Corp Common Stock declared 0.08 dividend per share during the earnings announcement for Q2 2026.